Works matching IS 10781552 AND DT 2021 AND VI 27 AND IP 4

Results: 45

A novel agnostic tumor: NTRKoma.

Published in:

2021

By:

Ayasun, Ruveyda;
Guven, Deniz Can;
Gullu, Ibrahim

Publication type:

Editorial

Cost analysis of daratumumab therapy: Is there a cost benefit to using the recently approved subcutaneous product versus the IV product?

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 978, doi. 10.1177/1078155221993218

By:

Kading, Mary;
Beck, Bradley

Publication type:

Article

Dose-escalation strategy in refractory metastatic colorectal cancer: A change in terms of cost-effectiveness.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 974, doi. 10.1177/1078155221992546

By:

Giuliani, Jacopo;
Fiorica, Francesco;
Ponturo, Giovanni;
Azzurro, Maurizio;
Ruzzenente, Andrea;
Bonetti, Andrea

Publication type:

Article

International Society of Oncology Pharmacy Practitioners (ISOPP) position statement: Role of the oncology pharmacy team in cancer care.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 785, doi. 10.1177/10781552211017199

By:

Holle, Lisa M;
Bilse, Tegan;
Alabelewe, Ramatu Masud;
Kintzel, Polly E;
Kandemir, Esin Aysel;
Tan, Chia Jie;
Weru, Irene;
Chambers, Carole R;
Dobish, Roxanne;
Handel, Evelyn;
Tewthanom, Karunrat;
Saeteaw, Manit;
Dewi, Luh Komang Mela;
Schwartz, Rowena;
Bernhardt, Brooke;
Garg, Manju;
Chatterjee, Ashraf;
Manyau, Pinky;
Chan, Alexandre;
Bayraktar-Ekincioglu, Aygin

Publication type:

Article

Corrigendum to Ammonia level as a proxy of asparaginase inactivation in children: A strategy for classification of infusion reactions.

Published in:: 2021
Publication type:: Correction Notice

How to conduct integrated pharmaceutical care for patients with hand-foot syndrome associated with chemotherapeutic agents and targeted drugs.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 919, doi. 10.1177/10781552211009291

By:

Chen, Jiexiu;
Wang, Zhuo

Publication type:

Article

Comment on Ammonia level as a proxy of asparaginase inactivation in children: A strategy for classification of infusion reactions.

Published in:

2021

By:

Tong, Wing H

Publication type:

Letter

Updates on the molecular mechanisms of aspirin in the prevention of colorectal cancer: Review.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 954, doi. 10.1177/1078155220984846

By:

Belayneh, Yaschilal Muche;
Amare, Gedefew Getnet;
Meharie, Birhanu Geta

Publication type:

Article

Assessing the risk of venous thromboembolism (VTE) in ambulatory patients with cancer: Rationale and implementation of a pharmacist-led VTE risk assessment program in an ambulatory cancer centre.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 911, doi. 10.1177/10781552211004705

By:

Pelletier, Ryan

Publication type:

Article

Long-term control in a patient with metastatic lung adenocarcinoma after discontinuation of nivolumab.

Published in:

2021

By:

Satoh, Hiroaki;
Miyazaki, Kunihiko;
Shiozawa, Toshihiro;
Kagohashi, Katsunori

Publication type:

Letter

Re: Long-term control in a patient with metastatic lung adenocarcinoma after discontinuation of nivolumab.

Published in:

2021

By:

Pampín-Sánchez, R;
Barbazán-Vázquez, FJ;
Fernández-González, B;
Rodríguez-de-Castro, B;
Aparicio-Carreño, C;
Sampedro-Gimeno, T

Publication type:

Letter to the Editor

Ambulatory chemotherapy: Past, present, and future.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 962, doi. 10.1177/1078155220985916

By:

Sabbagh Dit Hawasli, Racha;
Barton, Stephen;
Nabhani-Gebara, Shereen

Publication type:

Article

Response to comment on Ammonia level as a proxy of asparaginase inactivation in children: A strategy for classification of infusion reactions.

Published in:

2021

By:

Santos, Amanda C;
Land, Marcelo G P;
Lima, Elisangela C

Publication type:

Letter

Clinical controversies in the treatment of cancer-associated venous thromboembolism.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 939, doi. 10.1177/1078155220984371

By:

Nachar, Victoria R;
Schepers, Allison J

Publication type:

Article

Unleashing the power of immunotherapy and targeted therapy combinations: Advancing cancer care or discovering unknown toxicities?

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 930, doi. 10.1177/1078155220984235

By:

Przybylski, Daniel J;
Bergsbaken, Jason J;
Piccolo, Jennifer K

Publication type:

Article

A multicenter review of infusion-related reactions to daratumumab for relapsed multiple myeloma in the real world setting.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 907, doi. 10.1177/1078155220967738

By:

Geirnaert, Marc;
Howarth, Jacy;
Martin, Kristen;
Ricard, Chad;
Streilein, Scott;
Wasney, Danica;
Dao, Vi;
Kotb, Rami;
Rimmer, Emily;
Minuk, Leonard

Publication type:

Article

Interstitial nephritis with pembrolizumab: A case report and review.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 1046, doi. 10.1177/1078155220961553

By:

Peláez Bejarano, A;
Montero Pérez, O;
Inoriza Rueda, A;
Garrido Martínez, MT

Publication type:

Article

Central diabetes insipidus induced by temozolomide: A report of two cases.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 1040, doi. 10.1177/1078155220961551

By:

Mahiat, Cédric;
Capes, Antoine;
Duprez, Thierry;
Whenham, Nicolas;
Duck, Lionel;
Labriola, Laura

Publication type:

Article

Lorlatinib induced proteinuria: A case report.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 1037, doi. 10.1177/1078155220961549

By:

Lee, Chung-Shien;
Wanchoo, Rimda;
Seetharamu, Nagashree

Publication type:

Article

A case of successful acyclovir desensitization in a bone marrow transplant patient.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 1033, doi. 10.1177/1078155220959408

By:

Andrade, Diana C;
Fatakhova, Mariya;
Fatteh, Shahnaz;
Rubio-Gomez, Heysu

Publication type:

Article

Exemestane induced cholestatic liver injury – A case report.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 1029, doi. 10.1177/1078155220957726

By:

Fritzsche, Dane;
Indorf, Amy;
Miske, Abby;
Banda, Kalyan

Publication type:

Article

Atezolizumab-induced hemolytic anemia – A case report.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 1026, doi. 10.1177/1078155220957720

By:

Younce, Christina M;
Lawton, Jessica M;
Patel, Dhimant R

Publication type:

Article

Hypertriglyceridemia induced by S-1: A novel case report and review of the literature.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 1020, doi. 10.1177/1078155220956691

By:

Saito, Yoshitaka;
Takekuma, Yoh;
Komatsu, Yoshito;
Sugawara, Mitsuru

Publication type:

Article

Case report on 5-fluorouracil induced cerebrovascular accident.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 1016, doi. 10.1177/1078155220954900

By:

Karthikeyan, Kavya;
Babu, Christy M;
Shaji, Shintu;
Ashok, Ashwin M;
Madhu, CS

Publication type:

Article

Acute cardiomyopathy following a single dose of doxorubicin in a patient with adult T-Cell leukemia/lymphoma.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 1011, doi. 10.1177/1078155220953886

By:

Farina, Kyle;
Kalac, Matko;
Kim, Sara

Publication type:

Article

Safe administration of chemotherapy in mast cell activation syndrome.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 1005, doi. 10.1177/1078155220953879

By:

Lythgoe, MP;
Krell, J;
McNeish, IA;
Tookman, L

Publication type:

Article

Significant interaction between high-dose methotrexate and high-dose piperacillin-tazobactam causing reversible neurotoxicity and renal failure in an osteosarcoma patient.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 1000, doi. 10.1177/1078155220953878

By:

Krämer, Irene;
Rosentreter, Jelena;
Fried, Marius;
Kühn, Michael

Publication type:

Article

Alternative use of BRAF inhibitors in patients with metastatic melanoma unable to swallow pills.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 996, doi. 10.1177/1078155220953877

By:

Darrigade Fleury, M;
Masson Regnault, Marie;
Cales, S;
Frouin, E;
Wierbiecka-Hainaut, Ewa

Publication type:

Article

Tagraxofusp followed by combined azacitidine and venetoclax in blastic plasmacytoid dendritic cell neoplasm: A case report and literature review.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 990, doi. 10.1177/1078155220951850

By:

Samhouri, Yazan;
Ursu, Sorana;
Dutton, Nina;
Tanvi, Verma;
Fazal, Salman

Publication type:

Article

68-months progression-free survival with crizotinib treatment in a patient with metastatic ALK positive lung adenocarcinoma and sarcoidosis: A case report.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 984, doi. 10.1177/1078155220951242

By:

Tanriverdi, Ozgur;
Tarimer, Mehmet L;
Pak, Ceren D;
Uylas, Selcuk;
Alkan, Ali;
Celik, Ozgur Ilhan;
Kilic, Rabia M;
Zeybek, Arife

Publication type:

Article

Acute pancreatitis in a patient treated with imatinib and gefitinib.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 980, doi. 10.1177/1078155220949639

By:

Escudero-Vilaplana, Vicente;
Collado-Borrell, Roberto;
Villanueva-Bueno, Cristina;
Álvarez, Rosa;
Herranz, Ana;
Sanjurjo, María

Publication type:

Article

Assessment of extended urine protein monitoring frequency in patients receiving bevacizumab.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 902, doi. 10.1177/1078155220943959

By:

Schiffer, Molly;
Zukovic, Lejla;
Hall, Sophia;
Merl, Man Yee

Publication type:

Article

Impact of clinical pharmacists in an inpatient medical oncology service: A prospective study at a comprehensive cancer center in Jordan.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 897, doi. 10.1177/1078155220943277

By:

Faqeer, Nour;
Mustafa, Nour;
Abd Al-jalil, Noor;
Qur'an, Tasnim

Publication type:

Article

Differences in safety profiles of newly approved medications for multiple myeloma in real-world settings versus randomized controlled trials.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 887, doi. 10.1177/1078155220941937

By:

Borrelli, Eric P;
McGladrigan, Conor G

Publication type:

Article

Real-world data on patients with metastatic non-small-cell lung cancer treated with checkpoint inhibitors in an Italian Teaching Hospital in 2015–2018.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 877, doi. 10.1177/1078155220941586

By:

Veraldi, Marianna;
Esposito, Stefania;
Naturale, Maria D.;
Oradei, Marco;
Cosco, Donato;
Francesco, Adele E. De;
Cicchetti, Americo;
Bidino, Rossella Di

Publication type:

Article

Efficacy of a conversion from filgrastim to filgrastim-sndz in stem cell transplant patients undergoing mobilization.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 871, doi. 10.1177/1078155220941582

By:

Curry, Lauren D;
Anders, Brandi;
Dressler, Emily V;
Kennedy, LeAnne

Publication type:

Article

Risk reduction in a cancer chemotherapy production unit: Contribution of an automated drug dispensing system.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 863, doi. 10.1177/1078155220941060

By:

Ouedraogo, Jean-Marie;
Baraka, Soumaya El;
Adade, Casimir Adade;
Sitsopeh, Joseph;
Sessouma, Abou;
Belahcen, Mohammed Jaouad;
Rahali, Younes

Publication type:

Article

Tacrolimus dose modification in patients receiving concomitant isavuconazole after hematopoietic stem cell transplantation.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 857, doi. 10.1177/1078155220940416

By:

Trifilio, Steven;
Rubin, Halina;
Monacelli, Alexandra;
Mehta, Jayesh

Publication type:

Article

Physicochemical stability study of MYL-1401O, a biosimilar of trastuzumab, following a transient temperature excursion.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 847, doi. 10.1177/1078155220940410

By:

Guyader, Guillaume Le;
Vieillard, Victoire;
Paul, Muriel

Publication type:

Article

Glioblastoma and bevacizumab in elderly patients: Monocentric study.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 842, doi. 10.1177/1078155220940396

By:

Barrascout, Eduardo;
Lamuraglia, Michele

Publication type:

Article

Use of active learning and simulation to teach pharmacy students order verification and patient education best practices with oral oncolytic therapies.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 834, doi. 10.1177/1078155220940395

By:

Duffy, Alison P;
Henshaw, Alyssa;
Trovato, James A

Publication type:

Article

Physical and chemical stability of cytarabine in polypropylene syringes.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 827, doi. 10.1177/1078155220937405

By:

Ayed, Wiem Ben;
Drira, Chema;
Soussi, Mohamed Ali;
Ouesleti, Hanen;
Hamdene, Besma;
Khrouf, Myriam;
Safta, Fathi;
Fradi, Ines

Publication type:

Article

Characterization of relapse patterns in patients with acute lymphoblastic leukemia treated with blinatumomab.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 821, doi. 10.1177/1078155220934853

By:

Lau, Kimberly M;
Saunders, Ila M;
Goodman, Aaron M

Publication type:

Article

Incorporating a clinical oncology pharmacist into an ambulatory care pharmacy in pediatric hematology–oncology and transplant clinic: Assessment and significance.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 815, doi. 10.1177/1078155220934167

By:

Ali, Kashif;
Al-Quteimat, Osama;
Naseem, Rida;
Malhi, Saima Mehmood;
wajdi, Mehwish;
Jahan, Noor;
Ansari, Saqib Hussain;
Shamsi, Tahir Sultan

Publication type:

Article

Identification of target small molecule tyrosine kinase inhibitors that need monitoring and clinical application of protocol for early detection of cancer therapeutics-related cardiac dysfunction using signal detection: An investigation of real world data

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 804, doi. 10.1177/1078155220930367

By:

Mizuno, Takahito;
Sakai, Takamasa;
Tanabe, Kouichi;
Kozaki, Koji;
Umemura, Takumi;
Higashikawa, Mariko;
Kimura, Tomoki;
Yamada, Tetsuya;
Goto, Nobuyuki;
Ohtsu, Fumiko

Publication type:

Article